Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review

被引:0
|
作者
Ioannis Asproudis
Andreas Katsanos
Nikolaos Kozeis
Alexandra Tantou
Anastasios G. Konstas
机构
[1] University of Ioannina,Department of Ophthalmology
[2] Ophthalmica Institute,1st and 3rd University Departments of Ophthalmology
[3] Aristotle University of Thessaloniki,undefined
来源
Advances in Therapy | 2017年 / 34卷
关键词
Anti-TNF; Biological agents; DMARDS; Juvenile idiopathic arthritis; JIA; Methotrexate; Topical steroids; Uveitis;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic uveitis is a common extra-articular manifestation of juvenile idiopathic arthritis. The classic clinical picture is one of chronic anterior uveitis, which usually remains asymptomatic until ocular complications arise. The risk of uveitis is increased in girls with an early onset of oligoarthritis and positive antinuclear antibodies. Even though the inflammation in patients with juvenile idiopathic arthritis is initially limited in the anterior part of the eye, chronic active inflammation may eventually cause significant damage to the posterior pole. Complications may include band keratopathy, cataract, secondary glaucoma, posterior synechiae, cystoid macular edema, and hypotony. The cooperation of ophthalmologists with rheumatologists may help define the best treatment plan. The ophthalmic therapeutic regimen includes topical corticosteroids and mydriatics, while in severe cases immunosuppressive and biological agents are introduced. Surgical management of complications might be needed.
引用
收藏
页码:2558 / 2565
页数:7
相关论文
共 50 条
  • [21] Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
    Oray, Merih
    Tugal-Tutkun, Ilknur
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2016, 46 (02): : 77 - 82
  • [22] ABATACEPT IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED WITH UVEITIS
    Galstian, L.
    Zholobova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 845 - 845
  • [23] Update on biologicals for treatment of juvenile idiopathic arthritis
    Horneff, Gerd
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (03) : 361 - 376
  • [24] Update on the medical treatment of juvenile idiopathic arthritis
    Hashkes P.J.
    Laxer R.M.
    Current Rheumatology Reports, 2006, 8 (6) : 450 - 458
  • [25] Update on the pathogenesis and treatment of juvenile idiopathic arthritis
    Giancane, Gabriella
    Alongi, Alessandra
    Ravelli, Angelo
    CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (05) : 523 - 529
  • [26] Ocular outcome in patients with juvenile idiopathic arthritis and uveitis
    Meling, OE
    Flato, B
    Sandvig, KU
    Forre, O
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S93 - S93
  • [27] Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis
    C Tappeiner
    M Roesel
    C Heinz
    H Michels
    G Ganser
    A Heiligenhaus
    Eye, 2009, 23 : 1192 - 1198
  • [28] Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis
    Tappeiner, C.
    Roesel, M.
    Heinz, C.
    Michels, H.
    Ganser, G.
    Heiligenhaus, A.
    EYE, 2009, 23 (05) : 1192 - 1198
  • [29] Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
    R Joos
    C Wouters
    J Dehoorne
    D Elewaut
    Pediatric Rheumatology, 9 (Suppl 1)
  • [30] Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
    Iannone, Claudia
    Marelli, Luca
    Costi, Stefania
    Pellico, Maria Rosa
    La Franca, Lamberto
    Caporali, Roberto
    Miserocchi, Elisabetta
    CHILDREN-BASEL, 2023, 10 (03):